Related Experiment Video
Updated: Jun 4, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Synbiotics could not reduce the scoring of childhood atopic dermatitis (SCORAD): a randomized double blind
Alireza Shafiei1, Mostafa Moin, Zahra Pourpak
1Department of Allergy and Immunology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Insights
Synbiotic supplementation did not significantly decrease the severity of atopic dermatitis (AD) in children. This study challenges the effectiveness of synbiotics for treating childhood AD, indicating a need for further research.
Area of Science:
- Pediatrics
- Immunology
- Gastroenterology
Background:
- Atopic dermatitis (AD) is a common inflammatory skin condition in children.
- The efficacy of synbiotics (probiotics plus prebiotics) for AD treatment remains inconclusive.
- Existing evidence on synbiotics for childhood AD shows variable results.
Purpose of the Study:
- To evaluate the effectiveness of synbiotic supplementation in reducing the severity of atopic dermatitis in infants and young children.
- To determine if synbiotic intervention offers a significant benefit over placebo in managing childhood AD symptoms.
Main Methods:
- A randomized, double-blind, placebo-controlled trial involving 41 infants aged 1-36 months with moderate to severe AD.
- Participants received daily synbiotic or placebo powder for two months, with permitted use of emollients and topical corticosteroids.
- Severity of atopic dermatitis was assessed using the SCORAD index, alongside Skin Prick Tests (SPT), IgE levels, and eosinophil counts.
Main Results:
- Overall, participants experienced a significant reduction in SCORAD scores (Total SCORAD decreased by 56%, Objective SCORAD by 53%).
- No statistically significant difference was observed in the mean decrease of total SCORAD between the synbiotic group (24.2) and the placebo group (22.3).
- Subgroup analyses based on demographic, clinical, and paraclinical factors also revealed no significant differences between the intervention groups.
Conclusions:
- Synbiotic supplementation did not demonstrate a significant effect in decreasing the severity of atopic dermatitis in the studied pediatric population.
- The findings do not support the use of synbiotics as an effective treatment for childhood atopic dermatitis.
- Further research is warranted to fully elucidate the role, if any, of synbiotics in managing pediatric AD.
Abstract:
Despite preliminary evidence, the role of probiotic and synbiotic in treatment of the atopic dermatitis has shown varying results. We aimed to evaluate whether synbiotic supplementation decrease severity of atopic dermatitis (AD) in childhood. In a randomized double blind-placebo controlled trial, we evaluated the synbiotic supplementation efficiency on the treatment of atopic dermatitis. Infants aged 1-36 months with moderate to severe atopic dermatitis were randomized (n=41) and received either synbiotic (probiotic plus prebiotic) (n=20) or placebo (n=21) daily as a powder for two months. Emollient (Eucerin) and topical corticosteroid (Hydrocortisone) were permitted. Children were scored for severity of atopic dermatitis (SCORAD). Also allergen Skin Prick Tests (SPT), IgE blood level and eosinophil count were measured at first visit. Patients' SCORAD were reevaluated at the end of intervention. We followed 36 out of 41 subjects for two months (drop out rate = 9%). In the whole group, the mean Total SCORAD (at base line 40.93) decreased by 56% (p=0.00). The mean Objective SCORAD (at base line 31.29) decreased by 53% (p=0.00). There was no significant difference in the mean decrease of total SCORAD between placebo (22.3) and synbiotic groups (24.2). There was also no difference between two intervention groups in the mean decrease of total SCORAD regarding to different demographic, clinical and para clinical subgroups. This study could not confirm synbiotic as an effective treatment for childhood atopic dermatitis and further studies are needed. These findings challenge the role of synbiotics in the treatment of childhood atopic dermatitis.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Blinding
Acne Infection